BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 16135917)

  • 1. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
    Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
    Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
    Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
    Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of sentinel lymph node identification: background and clinical implications.
    Cochran AJ; Essner R; Rose DM; Glass EC
    Langenbecks Arch Surg; 2000 Jul; 385(4):252-60. PubMed ID: 10958508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
    Morton DL; Hoon DS; Cochran AJ; Turner RR; Essner R; Takeuchi H; Wanek LA; Glass E; Foshag LJ; Hsueh EC; Bilchik AJ; Elashoff D; Elashoff R
    Ann Surg; 2003 Oct; 238(4):538-49; discussion 549-50. PubMed ID: 14530725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
    ; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
    JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
    Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
    Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.
    Miura K; Hirakawa H; Uemura H; Yoshimoto S; Shiotani A; Sugasawa M; Homma A; Yokoyama J; Tsukahara K; Yoshizaki T; Yatabe Y; Matsuo K; Ohkura Y; Kosuda S; Hasegawa Y
    Auris Nasus Larynx; 2017 Jun; 44(3):319-326. PubMed ID: 27496008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).
    Faries MB; Thompson JF; Cochran A; Elashoff R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ; Morton DL;
    Ann Surg Oncol; 2010 Dec; 17(12):3324-9. PubMed ID: 20614193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
    Yao KA; Hsueh EC; Essner R; Foshag LJ; Wanek LA; Morton DL
    Ann Surg; 2003 Nov; 238(5):743-7. PubMed ID: 14578738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    Wagner JD; Davidson D; Coleman JJ; Hutchins G; Schauwecker D; Park HM; Havlik RJ
    Ann Surg Oncol; 1999 Jun; 6(4):398-404. PubMed ID: 10379863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
    Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
    Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete lymph node dissection for regional nodal metastasis.
    Dzwierzynski WW
    Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
    Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
    Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma.
    Haigh PI; Lucci A; Turner RR; Bostick PJ; Krasne DL; Stern SL; Morton DL
    Cancer; 2001 Aug; 92(3):535-41. PubMed ID: 11505397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.